NEW YORK (GenomeWeb) – Takara Bio USA Holdings will acquire instruments manufacturer WaferGen Biosystems, the companies announced today.

Under the terms of the deal, Takara Bio USA — formerly known as Clontech Laboratories and now a subsidiary of life science company Takara Bio — will pay an aggregate cash price based on a multiple of WaferGen's 2016 calendar year revenues, capped at $50 million. The multiple will be between one and three-and-a-half times WaferGen's full year 2016 revenues — if revenues exceed $9 million, the multiple will be capped at three-and-a-half times.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.